scispace - formally typeset
P

Patricia M. Kearney

Researcher at University College Cork

Publications -  344
Citations -  33955

Patricia M. Kearney is an academic researcher from University College Cork. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 46, co-authored 311 publications receiving 29401 citations. Previous affiliations of Patricia M. Kearney include National University of Ireland, Galway & Clinical Trial Service Unit.

Papers
More filters
Journal ArticleDOI

Global burden of hypertension: analysis of worldwide data

TL;DR: The overall prevalence and absolute burden of hypertension in 2000 and the global burden in 2025 were estimated to be about 1.56 billion (1.54-1.58 billion) and the number of adults with hypertension in 2025 was predicted to increase by about 60% respectively.
Journal ArticleDOI

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

TL;DR: Statin therapy can safely reduce the 5-year incidence of major coronary events, coronary revascularisation, and stroke by about one fifth per mmol/L reduction in LDL cholesterol, largely irrespective of the initial lipid profile or other presenting characteristics.
Journal ArticleDOI

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

TL;DR: In primary prevention without previous disease, aspirin is of uncertain net value as the reduction in occlusive events needs to be weighed against any increase in major bleeds.
Journal ArticleDOI

Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.

TL;DR: Global hypertension disparities are large and increasing and collaborative efforts are urgently needed to combat the emerging hypertension burden in low- and middle-income countries.
Journal ArticleDOI

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

TL;DR: Among people with diabetes the proportional effects of statin therapy were similar irrespective of whether there was a prior history of vascular disease and irrespective of other baseline characteristics and should be considered for all diabetic individuals who are at sufficiently high risk of vascular events.